Myeloid Cells in Circulation and Tumor Microenvironment of Colorectal Cancer Patients with Early and Advanced Disease Stages.

GMCs were lower with higher levels of tumor budding (low: 61.7 ± 7.5%, intermediate: 53.3 ± 9.9%, and high: 44.4 ± 8.4%), while IMCs showed an increasing trend (low: 31.3 ± 7.6%, intermediate: 40.6 ± 10.3%, and high: 49.7 ± 8.4%).

also in 63,971 other papers

MMCs also showed a trend of increase in advanced stages (early stages: 5.8 ± 0.6% and advanced stages: 7.7 ± 1.3%; Figure 4(b) ), while IMCs (early stages: 0.1 ± 0.03% and advanced stages: 0.2 ± 0.02%; Figure 4(b) ) and APCs (early stages: 7.7 ± 0.8% and advanced stages: 9.4 ± 1.0%; Figure 4(b) ) showed similar levels in both staging groups. 3.5.

also in 53,322 other papers